Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:

Abstract for IMM90001

Immunotoxicity of Isophorone Diisocyanate Contact Hypersensitivity Studies in Female B6C3F1 Mice

CASRN: 4098-71-9
Chemical Formula: C12H18N2O2
Molecular Weight: 222.2862


The following abstract presents results of a study conducted by a contract laboratory for the National Toxicology Program. The findings have not been peer reviewed and were not evaluated in accordance with the levels of evidence criteria established by NTP in March 2009. The findings and conclusions for this study should not be construed to represent the views of the NTP or the U.S. Government.


Isophorone diisocyanate, which is resistant to light discoloration and chemical attack, is used as an intermediate for polyurethanes and as a raw material in paints, varnishes, and elastomers. It was selected for evaluation as a sensitizing agent for contact hypersensitivity in mice.


Isophorone diisocyanate (< 99% purity) was obtained from the Aldrich Chemical Corp., Milwaukee, WI (Lot #02217JT) and was prepared in acetone/olive oil (4:1), which also served as the vehicle. Primary irritancy studies indicated that 1.0% isophorone diisocyanate was the minimum irritating concentration and treatment with 3.0% isophorone diisocyanate resulted in an irritation response nearly twice as great as 1.0%. Female B6C3F1 mice were sensitized dermally to either 0, 0.1%, 0.3%, or 1.0% solutions of isophorone diisocyanate daily for 5 consecutive days and challenged 7 days later with a 3.0% solution. A 0.5% solution of 1-fluoro-2,4-dinitrobenzene (DNFB, Sigma Chem. Corp.; Lot No. 88F-3833; > 99.0% pure as determined by HPLC), was used as a positive control. Site preparation included dermabrasion as well as intradermal injection of Freund's complete adjuvant in some mice. Mice were divided into 10 treatment groups of 8 mice/group as shown in Table 1. The irritancy response was determined by monitoring the extravasation of 125I-bovine serum albumin into the treated area. The contact hypersensitivity response was determined by monitoring the infiltration of 125I-iododeoxyuridine labeled cells into the challenge site.


There were no treatment-related effects on survival or body weights. Hypersensitivity responses as determined using the radioisotope procedure. A statistically significant hypersensitivity response was elicited in mice using a sensitizing concentration of 1.0% and a challenge concentration of 3.0%, with or without pretreatment with Freund's complete adjuvant (Groups 5 and 10). The positive control group (6) produced a statistically significant contact hypersensitivity response at a sensitizing and challenge concentration of 0.5% DNFB.


Under these experimental conditions, a contact hypersensitivity response to isophorone diisocyanate was observed in mice whether or not the site of sensitization was prepared using Freund's complete adjuvant.


Table 1. Study Design: Contact Hypersensitivity Study with Isophorone Diisocyanate
Group (n) Description FCA Sensitization Challenge

1 (8) Vehicle + Vehicle Vehicle
2 (8) Baseline Control + Vehicle 3.0% IPDI
3 (8) Experimental + 0.1% IPDI 3.0% IPDI
4 (8) Experimental + 0.3% IPDI 3.0% IPDI
5 (8) Experimental + 1.0% IPDI 3.0% IPDI
6 (8) DNFB Positive Control - 0.5% DNFB 0.5% DNFB
7 (8) DNFB Negative Control - Vehicle 0.5% DNFB
8 (8) Baseline Control - Vehicle 3.0% IPDI
9 (8) Experimental - 0.3% IPDI 3.0% IPDI
10 (8) Experimental - 1.0% IPDI 3.0% IPDI

note: IPDI = Isophorone diisocyanate; FCA = Freund's complete adjuvant; DNFB = 1-fluoro-2,4-dinitrobenzene